CN102471800A - 阿尔茨海默病的诊断和治疗 - Google Patents

阿尔茨海默病的诊断和治疗 Download PDF

Info

Publication number
CN102471800A
CN102471800A CN2010800292599A CN201080029259A CN102471800A CN 102471800 A CN102471800 A CN 102471800A CN 2010800292599 A CN2010800292599 A CN 2010800292599A CN 201080029259 A CN201080029259 A CN 201080029259A CN 102471800 A CN102471800 A CN 102471800A
Authority
CN
China
Prior art keywords
snp
gene
chromosome
disease
alzheimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800292599A
Other languages
English (en)
Chinese (zh)
Inventor
J·威廉姆斯
M·J·欧文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College Cardiff Consultants Ltd
Original Assignee
University College Cardiff Consultants Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0911539A external-priority patent/GB0911539D0/en
Priority claimed from GB0913357A external-priority patent/GB0913357D0/en
Priority claimed from GB0917326A external-priority patent/GB0917326D0/en
Application filed by University College Cardiff Consultants Ltd filed Critical University College Cardiff Consultants Ltd
Publication of CN102471800A publication Critical patent/CN102471800A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775—Apolipopeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN2010800292599A 2009-07-03 2010-06-22 阿尔茨海默病的诊断和治疗 Pending CN102471800A (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0911539A GB0911539D0 (en) 2009-07-03 2009-07-03 Diagnosis of alzheimer's disease
GB0911539.5 2009-07-03
GB0913357.0 2009-07-31
GB0913357A GB0913357D0 (en) 2009-07-31 2009-07-31 Diagnosis of alzheimer's disease
GB0917326.1 2009-10-03
GB0917326A GB0917326D0 (en) 2009-10-03 2009-10-03 Diagnosis of alzheimer's disease
PCT/GB2010/001208 WO2011001135A2 (en) 2009-07-03 2010-06-22 Diagnosis and treatment of alzheimer's disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN2013102808899A Division CN103409511A (zh) 2009-07-03 2010-06-22 阿尔茨海默病的诊断和治疗

Publications (1)

Publication Number Publication Date
CN102471800A true CN102471800A (zh) 2012-05-23

Family

ID=43014386

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2010800292599A Pending CN102471800A (zh) 2009-07-03 2010-06-22 阿尔茨海默病的诊断和治疗
CN2013102808899A Pending CN103409511A (zh) 2009-07-03 2010-06-22 阿尔茨海默病的诊断和治疗

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN2013102808899A Pending CN103409511A (zh) 2009-07-03 2010-06-22 阿尔茨海默病的诊断和治疗

Country Status (8)

Country Link
US (3) US20120122703A1 (https=)
EP (2) EP2891723B1 (https=)
JP (2) JP5917395B2 (https=)
CN (2) CN102471800A (https=)
AU (1) AU2010267835C1 (https=)
CA (1) CA2766876C (https=)
NZ (1) NZ596614A (https=)
WO (1) WO2011001135A2 (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104102839A (zh) * 2013-11-16 2014-10-15 西安电子科技大学 一种基于多尺度网格曲面形状特征的阿尔茨海默病脑皮层自动分类方法
CN105969885A (zh) * 2016-06-24 2016-09-28 江苏雄鸣医药科技有限公司 一种阿尔兹海默症的基因诊断试剂盒
CN110100014A (zh) * 2016-10-31 2019-08-06 香港科技大学 用于检测阿尔茨海默病基因变体的组合物、方法和试剂盒
CN110607364A (zh) * 2019-11-01 2019-12-24 北京中医药大学 通过检测snp位点确定等位基因的基因型的方法

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2766876C (en) * 2009-07-03 2020-01-28 University College Cardiff Consultants Limited Variants of clu/apoj, picalm, abca7, cr1 and bin1 gene loci and the ms4a gene cluster for the diagnosis of alzheimer's disease
WO2011024035A1 (en) * 2009-08-27 2011-03-03 Institut Pasteur De Lille Method for determining the risk of occurrence of alzheimer's disease
GB201212334D0 (en) * 2012-07-11 2012-08-22 Warwick The Therapeutic targets for alzheimers disease
CN106978475A (zh) * 2016-08-17 2017-07-25 上海易瑞生物科技有限公司 一种阿尔茨海默氏病易感基因检测分型试剂盒及其应用
CN106290823A (zh) * 2016-10-18 2017-01-04 上海凯璟生物科技有限公司 一种阿尔兹海默综合症标志物abca7检测试剂盒和制备方法
US20210293794A1 (en) * 2017-02-24 2021-09-23 University Of Hawii Cancer Center Metabolic biomarkers for the identification and characterization of alzheimers disease
KR101933847B1 (ko) 2017-05-15 2018-12-28 조선대학교산학협력단 알츠하이머병 위험도와 관련된 apoe 프로모터 단일염기변이 및 이것의 용도
WO2018212371A1 (ko) * 2017-05-17 2018-11-22 조선대학교산학협력단 알츠하이머병 위험도와 관련된 apoe 프로모터 단일염기변이 및 이것의 용도
JP7399465B2 (ja) * 2017-05-15 2023-12-18 インフォメディテック・カンパニー，リミテッド アルツハイマー病の危険性と関連するａｐｏｅプロモーターの一塩基多型およびその使用
WO2019178167A1 (en) * 2018-03-13 2019-09-19 I2Dx, Inc. Electronic delivery of information in personalized medicine
EP3794345B1 (en) * 2018-05-18 2025-02-26 Anavex Life Sciences Corp. Optimized sigma-1 agonist method of responder selection and treatment
KR102561438B1 (ko) * 2020-11-04 2023-07-28 사회복지법인 삼성생명공익재단 뇌 아밀로이드 베타 축적 가능성을 예측하는 방법
JP7731540B2 (ja) * 2021-03-26 2025-09-01 国立研究開発法人農業・食品産業技術総合研究機構 アミロイドβ蓄積リスクの有無の指標とする方法、一塩基多型（ＳＮＰ）の存在又は非存在を検出する方法、組成物、及びキット
US20240203524A1 (en) * 2021-04-13 2024-06-20 Kyoto University Information processing method, information processing device, and storage medium
CL2021001380A1 (es) 2021-05-26 2022-01-14 Corporacion Centro Int De Biomedicina Icc Generación de un nuevo anticuerpo monoclonal sitio específico para la proteína tau y su uso como herramienta en biomarcadores específicos para la detección temprana de enfermedades neurodegenerativas y patologías involucradas con la proteína tau como alzheimer y otras demencias.
KR102775636B1 (ko) * 2022-03-15 2025-03-05 사회복지법인 삼성생명공익재단 유럽 인구 데이터 기반 알츠하이머병 치매의 발병 위험군 또는 조기 증상 발현 위험군, 기억상실형 경도인지장애의 발병 위험군 및/또는 아밀로이드β 침착에 대한 PET 양성 위험군을 예측하기 위한 정보를 제공하는 방법
CN114736963B (zh) * 2022-05-25 2023-03-24 首都医科大学宣武医院 一种用于预测阿尔茨海默病发病风险的物质的组合、试剂盒及应用
US12518859B2 (en) * 2023-07-26 2026-01-06 Helix, Inc. Systems and methods for providing test results of gene sequencing data on a recurring basis
KR102940935B1 (ko) * 2024-02-15 2026-03-17 이화여자대학교 산학협력단 고인지예비능 생체표지자로서의 snp 및 이의 이용

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2765591B1 (fr) * 1997-07-01 2002-08-09 Pasteur Institut Procede de diagnostic de la maladie d'alzheimer
WO2006138716A2 (en) * 2005-06-17 2006-12-28 Brt Laboratories, Inc. Thermodynamically defined gene specific primers
JP2007166962A (ja) * 2005-12-21 2007-07-05 Japan Health Science Foundation アルツハイマー病の予測または診断の方法
EP2082343A2 (en) * 2006-11-02 2009-07-29 Genizon Biosciences Inc. Genemap of the human genes associated with asthma disease
SG177960A1 (en) * 2007-04-17 2012-02-28 Santen Pharmaceutical Co Ltd Method for determination of onset risk of glaucoma
CA2766876C (en) * 2009-07-03 2020-01-28 University College Cardiff Consultants Limited Variants of clu/apoj, picalm, abca7, cr1 and bin1 gene loci and the ms4a gene cluster for the diagnosis of alzheimer's disease

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BERTRAM LARS等: "Genome-wide Association Analysis Reveals Putative Alzheimer"s Disease Susceptibility Loci in Addition to APOE", 《AMERICAN JOURNAL OF HUMAN GENETICS》 *
无: "refSNP ID: rs3851179", 《NCBI DBSNP》 *
无: "refSNP ID: rs561655", 《NCBI DBSNP》 *
无: "refSNP ID: rs592297", 《NCBI DBSNP》 *
无: "refSNP ID:rs11136000", 《NCBI DBSNP》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104102839A (zh) * 2013-11-16 2014-10-15 西安电子科技大学 一种基于多尺度网格曲面形状特征的阿尔茨海默病脑皮层自动分类方法
CN104102839B (zh) * 2013-11-16 2017-10-27 西安电子科技大学 一种基于多尺度网格曲面形状特征的阿尔茨海默病脑皮层自动分类方法
CN105969885A (zh) * 2016-06-24 2016-09-28 江苏雄鸣医药科技有限公司 一种阿尔兹海默症的基因诊断试剂盒
CN110100014A (zh) * 2016-10-31 2019-08-06 香港科技大学 用于检测阿尔茨海默病基因变体的组合物、方法和试剂盒
CN110607364A (zh) * 2019-11-01 2019-12-24 北京中医药大学 通过检测snp位点确定等位基因的基因型的方法
CN110607364B (zh) * 2019-11-01 2023-04-28 北京中医药大学 通过检测snp位点确定等位基因的基因型的方法

Also Published As

Publication number Publication date
EP2891723A1 (en) 2015-07-08
US20130288906A1 (en) 2013-10-31
NZ596614A (en) 2012-11-30
JP2014012007A (ja) 2014-01-23
HK1169455A1 (en) 2013-01-25
EP2891723B1 (en) 2017-10-04
JP2012531195A (ja) 2012-12-10
AU2010267835B2 (en) 2014-11-06
JP5917395B2 (ja) 2016-05-11
US20120122703A1 (en) 2012-05-17
CA2766876A1 (en) 2011-01-06
EP2449134B1 (en) 2016-07-27
US20150119264A1 (en) 2015-04-30
CN103409511A (zh) 2013-11-27
EP2449134A2 (en) 2012-05-09
WO2011001135A3 (en) 2011-06-30
JP5917460B2 (ja) 2016-05-18
CA2766876C (en) 2020-01-28
WO2011001135A9 (en) 2011-02-24
WO2011001135A2 (en) 2011-01-06
AU2010267835C1 (en) 2015-02-26
AU2010267835A1 (en) 2011-12-15

Similar Documents

Publication Publication Date Title
CN102471800A (zh) 阿尔茨海默病的诊断和治疗
Harold et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
CN103930568A (zh) 用于治疗、诊断和监测阿尔茨海默病的方法
US20100324154A1 (en) Assessing susceptibility to vascular disorders
US20110177509A1 (en) Risk factors and a therapeutic target for neurodegenerative disorders
US20160102353A1 (en) Polymorphisms Associated With Age-Related Macular Degeneration and Methods for Evaluating Patient Risk
US20110045486A1 (en) Susceptibility Gene For Alzheimer's Disease
US9127316B2 (en) Markers associated with Alzheimer'S disease
Cuenca-León et al. Familial hemiplegic migraine: linkage to chromosome 14q32 in a Spanish kindred
US20150153364A1 (en) Biomarkers for tangle-predominant dementia
US20120208718A1 (en) Schizophrenia treatment response biomarkers
AU2014265063B2 (en) Diagnosis and treatment of Alzheimer's disease
HK1169455B (en) Diagnosis and treatment of alzheimer's disease
JP2022150707A (ja) アミロイドβ蓄積リスクの有無の指標とする方法、一塩基多型（ＳＮＰ）の存在又は非存在を検出する方法、組成物、及びキット
Panitch Understanding the mechanisms and pathways of Alzheimer’s disease in APOE genotype sub-populations
Genet Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes
Lilius et al. 237 α1-antichymotrypsin is not a susceptibility gene for Alzheimer's disease in old Swedes
Troncoso Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120523